Iambic's new AI platform aims to accelerate drug development. Learn how it uses multimodal data to deliver candidates in 12-18 months.
Cheryl Nguyen
·
Rupt's 2026 sales strategy aims for a 30% lead boost. Learn how predictive analytics and targeted activations drive early-stage SaaS growth.
·
AbbVie commits $1.2B to Iambic's AI platform for faster drug discovery. See how AI speeds up identifying new therapies, reducing time and cost.
·
Founders: Avoid costly disputes and SEC penalties. Learn 5 key steps for shareholder agreements, compliance, and audits.
·
CRISPR AgBio will redefine food security by 2027. Understand how gene editing impacts crops, regulations, and investments in the next five years.
·
·
7 min read
New tech from startups re-architects fuel distribution for 2026. See how AI predicts demand with 90% accuracy & cuts costs.
·
·
7 min read
AI chip shortages threaten innovation. Will startups with new hardware like RISC-V democratize AI or shift bottlenecks by 2026? Find out why it matters.
·
·
8 min read
CRISPR gene-editing patents impact future treatments. Learn why biotech IP disputes, like Broad vs. UC Berkeley, matter for patient access.
·
·
6 min read
How did Seqirus succeed in the UK pharma market? Learn their strategy for vaccine innovation and NHS partnerships. See what's next.
·
·
7 min read
The coming wave of spent lithium-ion batteries is a $30B problem. See why current recycling falls short and what regulations are changing.
·
·
7 min read
